Cargando…
Hepatocellular carcinoma surveillance: An evidence-based approach
Hepatocellular carcinoma (HCC) makes up 75%-85% of all primary liver cancers and is the fourth most common cause of cancer related death worldwide. Chronic liver disease is the most significant risk factor for HCC with 80%-90% of new cases occurring in the background of cirrhosis. Studies have shown...
Autores principales: | Harris, Patrick S, Hansen, Ross M, Gray, Meagan E, Massoud, Omar I, McGuire, Brendan M, Shoreibah, Mohamed G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452232/ https://www.ncbi.nlm.nih.gov/pubmed/30983815 http://dx.doi.org/10.3748/wjg.v25.i13.1550 |
Ejemplares similares
-
Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021) -
Liver Transplantation in Hepatitis B Reactivation in a Patient With Active HIV Viremia
por: Hegazy, Yassmin, et al.
Publicado: (2022) -
Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021) -
Update on hepatocellular carcinoma: Pathologists’ review
por: El Jabbour, Tony, et al.
Publicado: (2019) -
Molecular therapy for the treatment of hepatocellular carcinoma
por: Greten, T F, et al.
Publicado: (2009)